JP2025508819A5 - - Google Patents
Info
- Publication number
- JP2025508819A5 JP2025508819A5 JP2024550128A JP2024550128A JP2025508819A5 JP 2025508819 A5 JP2025508819 A5 JP 2025508819A5 JP 2024550128 A JP2024550128 A JP 2024550128A JP 2024550128 A JP2024550128 A JP 2024550128A JP 2025508819 A5 JP2025508819 A5 JP 2025508819A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263313943P | 2022-02-25 | 2022-02-25 | |
| US63/313,943 | 2022-02-25 | ||
| PCT/US2023/063226 WO2023164618A1 (en) | 2022-02-25 | 2023-02-24 | Cancer treatment with a conditionally active anti-ror2 antibody-drug conjugate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508819A JP2025508819A (ja) | 2025-04-10 |
| JP2025508819A5 true JP2025508819A5 (https=) | 2026-02-16 |
| JPWO2023164618A5 JPWO2023164618A5 (https=) | 2026-02-16 |
Family
ID=87766744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550128A Pending JP2025508819A (ja) | 2022-02-25 | 2023-02-24 | 抗ｒｏｒ２抗体、抗体断片、それらの免疫コンジュゲートおよびそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250161472A1 (https=) |
| EP (1) | EP4482870A1 (https=) |
| JP (1) | JP2025508819A (https=) |
| KR (1) | KR20240153580A (https=) |
| CN (1) | CN119095877A (https=) |
| AU (1) | AU2023226070A1 (https=) |
| CA (1) | CA3244077A1 (https=) |
| MX (1) | MX2024010440A (https=) |
| TW (1) | TW202342537A (https=) |
| WO (1) | WO2023164618A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140322234A1 (en) * | 2012-01-03 | 2014-10-30 | The Board Of Trustees Of The Leland Stanford Junior University | Analysis and Targeting of ROR2 in Cancer |
| US11673957B2 (en) * | 2015-03-10 | 2023-06-13 | Eureka Therapeutics, Inc. | Anti-ROR2 antibodies |
| WO2017127702A1 (en) * | 2016-01-20 | 2017-07-27 | The Scripps Research Institute | Ror2 antibody compositions and related methods |
| CN116751298A (zh) * | 2016-05-13 | 2023-09-15 | 生物蛋白有限公司 | 抗ror2抗体、抗体片段和它们的免疫缀合物以及其用途 |
| BR112022009611A2 (pt) * | 2019-11-18 | 2022-08-09 | Univ California | Anticorpos anti-ror-2 e métodos de uso |
-
2023
- 2023-02-24 WO PCT/US2023/063226 patent/WO2023164618A1/en not_active Ceased
- 2023-02-24 KR KR1020247031146A patent/KR20240153580A/ko active Pending
- 2023-02-24 CA CA3244077A patent/CA3244077A1/en active Pending
- 2023-02-24 EP EP23760970.6A patent/EP4482870A1/en active Pending
- 2023-02-24 JP JP2024550128A patent/JP2025508819A/ja active Pending
- 2023-02-24 AU AU2023226070A patent/AU2023226070A1/en active Pending
- 2023-02-24 US US18/841,038 patent/US20250161472A1/en active Pending
- 2023-02-24 TW TW112106867A patent/TW202342537A/zh unknown
- 2023-02-24 CN CN202380036629.9A patent/CN119095877A/zh active Pending
- 2023-02-24 MX MX2024010440A patent/MX2024010440A/es unknown